C08L85/02

OLIGOMER OR POLYMER, COMPOSITION, USE OF THE OLIGOMER OR POLYMER AND INTERMEDIATE

The present invention relates to an oligomer or polymer, or to a composition comprising said oligomer or polymer, which are particularly useful as a stabiliser for organic materials. The present invention also relates to an intermediate for the synthesis of the above-mentioned oligomers or polymers.

Polyester film comprising a polymeric phosphonate flame retardant

A polyester film comprising a polymeric phosphonate flame retardant in an amount of from about 1.0 to about 25.0 wt % by total weight of the film and further comprising at least one metal cation selected from the group consisting of Group I and Group II metal cations.

Polyester film comprising a polymeric phosphonate flame retardant

A polyester film comprising a polymeric phosphonate flame retardant in an amount of from about 1.0 to about 25.0 wt % by total weight of the film and further comprising at least one metal cation selected from the group consisting of Group I and Group II metal cations.

SYSTEMS AND METHODS FOR OPTIMIZED PATIENT SPECIFIC TISSUE ENGINEERING VASCULAR GRAFTS

It has been established that optimizing cell seeding onto tissue engineering vascular grafts (TEVG) is associated with reduced inflammatory responses and reduced post-operative stenosis of TEVG. Cell seeding increased TEVG patency in a dose dependent manner, and TEVG patency improved when more cells were seeded, however duration of incubation time showed minimal effect on TEVG patency. Methods of engineering patient specific TEVG including optimal numbers of cells to maintain graft patency and reduce post-operative stenosis are provided. Closed, single-use customizable systems for seeding TEVG are also provided. Preferably the systems are custom-designed based on morphology of the patient specific graft, to enhance the efficacy of cell seeding.

SYSTEMS AND METHODS FOR OPTIMIZED PATIENT SPECIFIC TISSUE ENGINEERING VASCULAR GRAFTS

It has been established that optimizing cell seeding onto tissue engineering vascular grafts (TEVG) is associated with reduced inflammatory responses and reduced post-operative stenosis of TEVG. Cell seeding increased TEVG patency in a dose dependent manner, and TEVG patency improved when more cells were seeded, however duration of incubation time showed minimal effect on TEVG patency. Methods of engineering patient specific TEVG including optimal numbers of cells to maintain graft patency and reduce post-operative stenosis are provided. Closed, single-use customizable systems for seeding TEVG are also provided. Preferably the systems are custom-designed based on morphology of the patient specific graft, to enhance the efficacy of cell seeding.

Stent-graft with bioabsorbable structural support

A stent-graft comprising a tubular, radially self-expandable, braided structure comprising elongate bioabsorbable filaments, a bioabsorbable adhesive means, and a permanent graft disposed and adhered with the adhesive means to at least a portion of the structure and forming a stent-graft assembly, the permanent graft and the tubular structure are coextensive along at least a portion of the stent-graft.

Stent-graft with bioabsorbable structural support

A stent-graft comprising a tubular, radially self-expandable, braided structure comprising elongate bioabsorbable filaments, a bioabsorbable adhesive means, and a permanent graft disposed and adhered with the adhesive means to at least a portion of the structure and forming a stent-graft assembly, the permanent graft and the tubular structure are coextensive along at least a portion of the stent-graft.

Thermoplastic polycarbonate resin composition including aromatic polyphosphonate and organic acid and article produced therefrom

A thermoplastic resin composition comprises: about 100 parts by weight of a polycarbonate resin; about 50 parts by weight to about 250 parts by weight of a polyester resin; about 10 parts by weight to about 200 parts by weight of an aromatic polyphosphonate having a weight average molecular weight of about 65,000 g/mol to about 130,000 g/mol; and about 0.1 parts by weight to about 2 parts by weight of an organic acid comprising citric acid, lactic acid, malic acid, tartaric acid, and/or glycolic acid.

Thermoplastic polycarbonate resin composition including aromatic polyphosphonate and organic acid and article produced therefrom

A thermoplastic resin composition comprises: about 100 parts by weight of a polycarbonate resin; about 50 parts by weight to about 250 parts by weight of a polyester resin; about 10 parts by weight to about 200 parts by weight of an aromatic polyphosphonate having a weight average molecular weight of about 65,000 g/mol to about 130,000 g/mol; and about 0.1 parts by weight to about 2 parts by weight of an organic acid comprising citric acid, lactic acid, malic acid, tartaric acid, and/or glycolic acid.

Thermoplastic polycarbonate resin composition including aromatic polyphosphonate and organic acid and article produced therefrom

A thermoplastic resin composition comprises: about 100 parts by weight of a polycarbonate resin; about 50 parts by weight to about 250 parts by weight of a polyester resin; about 10 parts by weight to about 200 parts by weight of an aromatic polyphosphonate having a weight average molecular weight of about 65,000 g/mol to about 130,000 g/mol; and about 0.1 parts by weight to about 2 parts by weight of an organic acid comprising citric acid, lactic acid, malic acid, tartaric acid, and/or glycolic acid.